Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 2
1991 2
1992 1
1993 1
1995 1
1996 2
1998 4
1999 1
2000 4
2001 3
2002 7
2003 2
2004 4
2005 8
2006 3
2007 2
2008 1
2009 2
2010 3
2011 2
2012 2
2013 8
2014 4
2015 1
2016 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Results by year

Filters applied: . Clear all
Page 1
Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200.
Giantonio BJ, Catalano PJ, Meropol NJ, O'Dwyer PJ, Mitchell EP, Alberts SR, Schwartz MA, Benson AB 3rd; Eastern Cooperative Oncology Group Study E3200. Giantonio BJ, et al. J Clin Oncol. 2007 Apr 20;25(12):1539-44. doi: 10.1200/JCO.2006.09.6305. J Clin Oncol. 2007. PMID: 17442997 Corrected and republished. Clinical Trial.
Adult acute nonlymphocytic leukemia.
Cassileth PA. Cassileth PA. Med Clin North Am. 1984 May;68(3):675-95. doi: 10.1016/s0025-7125(16)31122-1. Med Clin North Am. 1984. PMID: 6379338 Review.
Phase II study of cisplatin and 5-fluorouracil (PF) and mitomycin C, vincristine, cisplatin and 5-fluorouracil (MVPF) in patients with metastatic large bowel cancer: an Eastern Cooperative Oncology Group study (EST 1285).
Pandya KJ, Lefkopoulou M, Petrelli NJ, Vaughn DJ, Smith TJ, Harris JE, Haller DG; Eastern Cooperative Oncology Group. Pandya KJ, et al. Oncology. 2004;66(2):118-25. doi: 10.1159/000077437. Oncology. 2004. PMID: 15138363 Clinical Trial.
Phase 2 study of preoperative radiation with concurrent capecitabine, oxaliplatin, and bevacizumab followed by surgery and postoperative 5-fluorouracil, leucovorin, oxaliplatin (FOLFOX), and bevacizumab in patients with locally advanced rectal cancer: ECOG 3204.
Landry JC, Feng Y, Cohen SJ, Staley CA 3rd, Whittington R, Sigurdson ER, Nimeiri H, Verma U, Prabhu RS, Benson AB. Landry JC, et al. Cancer. 2013 Apr 15;119(8):1521-7. doi: 10.1002/cncr.27890. Epub 2013 Jan 3. Cancer. 2013. PMID: 23288663 Free PMC article. Clinical Trial.
Report of a phase I evaluation of dose and schedule of interleukin-1 alpha and cyclophosphamide in patients with advanced tumors: An Eastern Cooperative Oncology Group study (PX990) and review of IL-1-based studies of hematopoietic reconstitution.
Dutcher JP, Neuberg D, Atkins MB, Tester WJ, Wadler S, Stewart JA, Chachoua A, Schuchter LM. Dutcher JP, et al. J Interferon Cytokine Res. 2014 May;34(5):376-84. doi: 10.1089/jir.2013.0010. Epub 2014 Jan 16. J Interferon Cytokine Res. 2014. PMID: 24433038 Free PMC article. Clinical Trial.
Phase III Southwest Oncology Group 9415/Intergroup 0153 randomized trial of fluorouracil, leucovorin, and levamisole versus fluorouracil continuous infusion and levamisole for adjuvant treatment of stage III and high-risk stage II colon cancer.
Poplin EA, Benedetti JK, Estes NC, Haller DG, Mayer RJ, Goldberg RM, Weiss GR, Rivkin SE, Macdonald JS. Poplin EA, et al. J Clin Oncol. 2005 Mar 20;23(9):1819-25. doi: 10.1200/JCO.2005.04.169. J Clin Oncol. 2005. PMID: 15774775 Clinical Trial.
69 results